BRIEF published on 09/27/2024 at 22:35, 1 year 7 months ago Nyxoah Presents Promising DREAM Study Data at ISSS 2024 FDA Approval Clinical Data Obstructive Sleep Apnea DREAM Study Genio Stimulation
BRIEF published on 09/27/2024 at 22:05, 1 year 7 months ago Orange: Information on share buyback operations Share Buyback Performance 2024 Orange Leaders
BRIEF published on 09/27/2024 at 22:01, 1 year 7 months ago FDA Grants Approval for Stelara® Biosimilar FYB202/OtulfiTM FDA Approval Pharmaceutical Formycon AG Biosimilar Stelara®
BRIEF published on 09/27/2024 at 21:36, 1 year 7 months ago Massive support from shareholders and creditors for Atos' rescue plan Shareholders Backup Plan Financial Restructuring Atos Commercial Court
BRIEF published on 09/27/2024 at 20:05, 1 year 7 months ago Armada Releases Annual Results Revenue Increase Shareholder Approval Annual Results Acquisition Agreement Comprehensive Loss
BRIEF published on 09/27/2024 at 20:05, 1 year 7 months ago POP Biotechnologies Announces Positive Interim Results for COVID-19 Vaccine Trial COVID-19 Vaccine Phase 3 Trial Immunogenicity EuCorVac-19 POP BIO SNAP
BRIEF published on 09/27/2024 at 20:05, 1 year 7 months ago Line5 Partners with Pauldron to Enhance Vehicle Protection Plans with Seamless Financing Customer Satisfaction Financing Solutions Seamless Integration Vehicle Protection Dealership Profitability
BRIEF published on 09/27/2024 at 19:24, 1 year 7 months ago SCOR to Acquire Remaining Shares of MRM Real Estate Investment Public Tender Offer Squeeze-out SCOR MRM
BRIEF published on 09/27/2024 at 19:15, 1 year 7 months ago Riber: Monthly information on share capital and voting rights Share Capital Voting Rights Actions AMF RIBER
BRIEF published on 09/27/2024 at 19:15, 1 year 7 months ago VusionGroup: Publication of the half-yearly financial report as of June 30, 2024 Financial Report 2024 Regulated Information VusionGroup Half
Published on 05/09/2026 at 00:00, 1 hour 38 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:00, 2 hours 38 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 3 hours 8 minutes ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 3 hours 8 minutes ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 20:38, 5 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 6 hours 25 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 6 hours 36 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 7 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 7 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
